EXETER AND DISTRICT KIDNEY PATIENTS' ASSOCIATION

Registered charity 276981 · accounts filings on the Charity Commission register · also known as EDKPA

Provide welfare for kidney patients being treated via Royal Devon & Exeter Hospital whether they are recently diagnosed, being treated for renal failure, on dialysis or after being transplanted.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£36k
Latest spending
£50k
Registered
1979
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported an excess of payments over receipts of £14,243 for the year ended 28 February 2025. Total assets less current liabilities stood at £489,302, with unrestricted cash reserves of £76,299. The trustees expressed confidence in their financial ability to continue work for the foreseeable future, noting that reserves are in excess of immediate needs despite reliance on unpredictable legacies.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Cornwall · Devon · Somerset

Income and spending

Financial year endIncomeSpending
28/02/2025£36k£50k
29/02/2024£13k£44k
05/04/2023£23k£24k
05/04/2022£20k£45k
05/04/2021£58k£32k

Common questions

Is EXETER AND DISTRICT KIDNEY PATIENTS' ASSOCIATION financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported an excess of payments over receipts of £14,243 for the year ended 28 February 2025. Total assets less current liabilities stood at £489,302, with unrestricted cash reserves of £76,299. The trustees expressed confidence in their financial ability to continue work for the foreseeable future, noting that reserves are in excess of immediate needs despite reliance on unpredictable legacies. Its FY2025 accounts were independently examined.